FDA Inspection Readiness

FDA Inspection Intelligence Built
by Former FDA Investigators

Former FDA investigators helping pharmaceutical, biotechnology, medical device, food, and cosmetics companies prepare for inspections, respond to FDA observations, and strengthen GMP compliance.

Step Inside a Regulated Facility

Get Inspection Ready Read the GMP Readiness Guide

Industry Universe

Step Inside Every
FDA-Regulated Environment

Explore cinematic walkthroughs of the facilities FDA investigators inspect. Each environment surfaces real risks, common 483 observations, and what investigators look for.

Pharmaceutical Manufacturing From dispensing to packaging — every cGMP control under one roof. Enter Environment Biologics Manufacturing Upstream, downstream, and aseptic fill — the biologics pressure points. Enter Environment Medical Device Manufacturing Design controls, CAPA, and complaint handling under 21 CFR 820 / QMSR. Enter Environment Food Manufacturing FSMA, allergen control, and environmental pathogen monitoring. Enter Environment Cosmetics Manufacturing MoCRA compliance — adverse event reporting and facility registration. Enter Environment Compounding Pharmacy USP <797>, <800>, and FDA 503B outsourcing facility expectations. Enter Environment QC Analytical Laboratory HPLC, dissolution, stability, LIMS — and the data integrity that ties them together. Enter Environment Microbiology Laboratory Sterility, endotoxin, EM — the sharp end of contamination control. Enter Environment

Former FDA Investigators   —   Mock FDA Inspection Experts   —   FDA 483 Response Specialists

Former FDA investigators consulting with a client team

Why Choose Us

Former FDA
Expertise

FDAInspections.com is led by former FDA investigators with direct agency experience helping regulated companies prepare for inspections, respond to observations, and improve inspection readiness.

  • Mock FDA Inspections
  • GMP Gap Analysis
  • FDA 483 Response Strategy
  • Warning Letter Remediation
Schedule Virtual Consulting

Core Services

FDA Inspection
Consulting Services

Comprehensive regulatory consulting from investigators who’ve been on both sides of the FDA inspection process.

01

Mock FDA Inspections

Realistic mock inspections conducted by former FDA investigators to identify vulnerabilities before the agency arrives.

Learn More
02

GMP Gap Analysis

Systematic evaluation of your quality systems against current FDA expectations and cGMP requirements.

Learn More
03

FDA 483 Response Support

Strategic response development to address inspectional observations and prevent escalation to warning letters.

Learn More
04

Warning Letter Response

Expert remediation planning and corrective action implementation to resolve FDA enforcement actions.

Learn More

Core Services

FDA Regulatory
Intelligence

Access curated FDA enforcement data and trend analysis to stay ahead of regulatory developments.

FDA Warning Letter Analysis

Searchable intelligence on FDA warning letters across industries, with trend analysis and compliance insights to benchmark your regulatory posture.

Explore Data

FDA 483 Observation Intelligence

Detailed analysis of FDA 483 observations by category, helping companies anticipate inspection focus areas and prepare targeted responses.

Explore Data

FDA Observations & Actions

Are the Result of Your Quality System.

learn

Training, Webinars, and Inspection Resources

Common Questions

Frequently Asked Questions

FDA inspection readiness means the facility, records, quality systems, and staff are prepared for FDA review before an investigator arrives.

An FDA Form 483 lists inspection observations. Companies should review each item, identify root causes, prepare corrective actions, and send a written response within the FDA response window.

Companies can prepare through mock inspections, GMP gap reviews, document checks, staff interview practice, CAPA review, and inspection-room planning.

FDA may issue a warning letter when inspection findings, product issues, records, responses, or repeated violations show that a company has not corrected regulatory problems.

A mock FDA inspection can find weak records, unclear staff answers, and quality system gaps before FDA sees them, giving the team time to correct problems.

Take Action

Prepare Before
FDA Arrives

Don’t wait for a Form 483 or warning letter to take action. Our team of former FDA investigators will assess your readiness and build a tailored compliance strategy.

Buy $495 Readiness Review Get FDA Help
Immersive Inspection